CDKN2A and acute lymphoblastic leukemia: The second most significant association signal was found for rs3731249 at CDKN2A. In this case, the CT/TT genotypes produced a 2.61-fold increased risk of B-ALL (95% CI: 1.38–4.92; P = 0.002).